ホーム › 頭頸部扁平上皮癌 › オハイオ › Cincinnati
Cincinnati、OHにおける頭頸部扁平上皮癌の臨床試験
Cincinnatiとその周辺地域（約30マイル以内）の拠点で、頭頸部扁平上皮癌に関する14件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
被験者募集中第2/3相
- Site#0117, Cincinnati
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
被験者募集中第3相
- University of Cincinnati, Cincinnati
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
被験者募集中第3相
- University of Cincinnati, Cincinnati
Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer
被験者募集中第2相
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- University of Cincinnati Cancer Center-West Chester, West Chester · 15マイル先
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
被験者募集中第2相
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Oncology Hematology Care Inc-Kenwood, Cincinnati
- 他4件
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
被験者募集中観察研究
- University of Cincinnati, Cincinnati
A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
被験者募集中第2相
- St. Elizabeth Healthcare, Edgewood · 8マイル先
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
被験者募集中第2相
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- University of Cincinnati Cancer Center-West Chester, West Chester · 15マイル先
Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin
被験者募集中第3相
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- University of Cincinnati Cancer Center-West Chester, West Chester · 15マイル先
Phase I/ II Trial Combining PD-1 Inhibition and Neoadjuvant Proton or Photon Radiation Therapy in Recurrent Head and Neck Squamous Cell Carcinoma
被験者募集中第1/2相
- University of Cincinnati Medical Center, Cincinnati
Reduced Elective Nodal and CTV Dose for HPV+ Oropharyngeal Squamous Cell Carcinoma
被験者募集中第2相
- University of Cincinnati Medical Center, Cincinnati
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
被験者募集中第1/2相
- Carl & Edyth Lindner Center for Research & Education at The Christ Hospital and The Christ Hospital Cancer Center, Cincinnati
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
被験者募集中第1/2相
- Research Site 113, Cincinnati
A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
被験者募集中第1/2相
- The Christ Hospital, Cincinnati
他の都市における頭頸部扁平上皮癌の試験
- Houston, TX47件の研究
- Los Angeles, CA42件の研究
- Boston, MA40件の研究
- Nashville, TN39件の研究
- New York City, NY39件の研究
- St. Louis, MO28件の研究
- Arlington, VA26件の研究
- Chicago, IL26件の研究
- Philadelphia, PA26件の研究
- Atlanta, GA24件の研究
- Pittsburgh, PA22件の研究
- New Haven, CT22件の研究
Cincinnatiにおける他の研究
- 非小細胞肺癌35件の研究
- がん（全種類）27件の研究
- 乳がん25件の研究
- 心不全24件の研究
- 大腸癌21件の研究
- 急性骨髄性白血病20件の研究
- 転移性癌20件の研究
- 卵巣がん19件の研究
- 肺がん19件の研究
- 肥満症19件の研究
- 前立腺がん18件の研究
- 多発性骨髄腫17件の研究
ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。